A new paper entitled ‘Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity’ was published this week in Clinical and Vaccine…
Read More
A new paper entitled ‘Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity’ was published this week in Clinical and Vaccine…
Variation Biotechnologies Inc. (VBI), a privately held biopharmaceutical company focused on the development of vaccines for infectious diseases using a novel platform technology, announced today it has secured US$35.7 million…